Australia markets close in 1 hour 23 minutes

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.7200+0.2500 (+7.20%)
At close: 03:59PM EST
3.7400 +0.02 (+0.54%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close3.4700
Open3.5000
Bid3.5400 x 1300
Ask3.7400 x 1300
Day's range3.4250 - 3.7300
52-week range0.9500 - 4.0400
Volume10,574
Avg. volume31,970
Market cap39.004M
Beta (5Y monthly)1.37
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Nephros Announces Results for Quarter Ended September 30, 2023

    Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022; Net Loss from Continuing Operations Narrows 85% to $0.2 Million; $1.1 Million in Positive Year-to-Date Net Cash Flows from Operating Activities SOUTH ORANGE, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2023.

  • GlobeNewswire

    Nephros Hires Judy Krandel as Chief Financial Officer

    SOUTH ORANGE, NJ, Nov. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, announced the appointment of Judy Krandel as Chief Financial Officer (CFO), effective today. In this role, Ms. Krandel will be responsible for directing the company’s finances and working closely with the Chief Executive Officer (CEO) and Board of Directors to develop and execute Nephros’s lon

  • GlobeNewswire

    Nephros Schedules Third Quarter 2023 Financial Results Conference Call

    SOUTH ORANGE, NJ, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November 8, 2023 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 31